Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-09

Clinical Trial Update: Colchicine and CRP in Atrial Fibrillation and AF Ablation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating colchicine and CRP in atrial fibrillation and AF ablation completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2019-05-09